SCHEMBL17416170

SCHEMBL17416170

CCCCCCCCCCCCSCCCN(CCCSCCCCCCCCCCCC)CCCN(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 4/20 0.54
ALDH1A1 P00352 2/20 0.39
TSHR P16473 1/20 0.39
THRB P10828 3/20 0.38
CES2 O00748 3/20 0.38
HSD17B10 Q99714 2/20 0.38
GMNN O75496 1/20 0.38
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C9 P11712 1/20 0.38
BLM P54132 1/20 0.38
ESR1 P03372 2/20 0.38
ESR2 Q92731 2/20 0.38
CA2 P00918 1/20 0.37
THRA P10827 1/20 0.36
CYP1A2 P05177 1/20 0.34
HRH2 P25021 1/20 0.34
HRH4 Q9H3N8 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17416214 1.00 DNM1 (0.54) DNM1ALDH1A1TSHRTHRBCES2
SCHEMBL17416110 0.92 DNM1 (0.48) DNM1ALDH1A1TSHRTHRBCES2
SCHEMBL17416208 0.92 DNM1 (0.48) DNM1ALDH1A1TSHRTHRBCES2
SCHEMBL17416199 0.86 CES2 (0.39) DNM1TSHRTHRBCES2HSD17B10
SCHEMBL17416198 0.86 CES2 (0.39) DNM1TSHRTHRBCES2HSD17B10
SCHEMBL23132630 0.83 DNM1 (0.64) DNM1ALDH1A1TSHRTHRBCES2
SCHEMBL20137213 0.83 DNM1 (0.56) DNM1ALDH1A1TSHRTHRBCES2
SCHEMBL17817257 0.83 DNM1 (0.56) DNM1ALDH1A1TSHRTHRBCES2
SCHEMBL6827760 0.83 DNM1 (0.56) DNM1ALDH1A1TSHRTHRBCES2
SCHEMBL11209342 0.83 DNM1 (0.79) DNM1ALDH1A1TSHRTHRBCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170204076-A1 SYNTHESIS AND USE OF AMINO LIPIDS SCREENFECT GMBH (DE) 2017-07-20 US disclosed
US-20170204076-A1 SYNTHESIS AND USE OF AMINO LIPIDS SCREENFECT GMBH (DE) 2017-07-20 US disclosed
US-20170204076-A1 SYNTHESIS AND USE OF AMINO LIPIDS SCREENFECT GMBH (DE) 2017-07-20 US disclosed
EP-2966068-A1 Synthesis and use of amino lipids Incella GmbH (DE) 2016-01-13 EP disclosed
EP-2966068-A1 Synthesis and use of amino lipids Incella GmbH (DE) 2016-01-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170204076-A1 SYNTHESIS AND USE OF AMINO LIPIDS ACSL4, PYM1, LPAR4 DNM1 1719/4885ALDH1A1 4417/4885TSHR 1047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.